J Stubbs, S Olugbile, B Saidou… - Infection and …, 2011 - Am Soc Microbiol It is widely accepted that antibody responses against the human parasitic pathogen Plasmodium falciparum protect the host from the rigors of severe malaria and death. However, there is a continuing need for the development of in vitro correlate assays of immune protection. To this end, ... Related articles - All 2 versions
[HTML] from plos.orgT Triglia, L Chen, S Lopaticki, C Dekiwadia… - PLoS Pathogens, 2011 - dx.plos.org The causative agent of the most severe form of malaria in humans is the protozoan parasite Plasmodium falciparum. These parasites are carried by a mosquito that infects humans during feeding resulting in injection of sporozoite forms that infect and develop in the liver into the merozoite ... Cited by 1 - Related articles - Cached - All 3 versions
JE Moon, GA Deye, L Miller, S Fracisco… - The American journal of …, 2011 - ASTMH Abstract.: A sensitive biomarker of malaria infection would obviate the need for placebo control arms in clinical trials of malaria prophylactic drugs. Antibodies to the 42-kDa fragment of merozoite surface protein-1 (MSP1 42 ) have been identified as a potential marker of malaria ... Related articles - All 3 versions
[HTML] from nih.govP Srinivasan, WL Beatty, A Diouf… - Proceedings of the …, 2011 - National Acad Sciences The commitment of Plasmodium merozoites to invade red blood cells (RBCs) is marked by the formation of a junction between the merozoite and the RBC and the coordinated induction of the parasitophorous vacuole. Despite its importance, the molecular events underlying the ...
C Bisseye, LM Yindom, J Simporé… - Clinical & …, 2011 - Wiley Online Library Page 1. An engineered Plasmodium falciparum C-terminal 19-kilodalton Merozoite Surface Protein 1 vaccine candidate induces high levels of IFN-gamma production ... 2 Page 3. Summary The 19-kDa C-terminal region of merozoite surface protein 1 (MSP119), a major blood ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
